CS MEDICA A/S Positioned for Strong Growth in Alternative Medicine Market

CS MEDICA, a Danish Med-Tech firm, has initiated with a "Buy" rating by NuWays AG, citing its innovation in CBD-infused medical devices. The company focuses on developing treatments for conditions like arthritis, stress, and hair loss. Their products, backed by clinical trials, are positioned in major markets such as the EU, U.K., and U.S.

The firm employs a capital-light model, emphasizing research and distribution, while outsourcing manufacturing. This approach helps minimize operational risks. Notably, CS MEDICA is one of the few companies registered to sell CBD devices in pharmacies, uniquely bridging pharmaceutical and cosmetic markets.

As global demand for alternative medicine grows, projected at a 15.7% CAGR until 2031, CS MEDICA stands to benefit significantly. Their private-label segment provides stable revenues, supporting the expansion of their CANNASEN® brand. Market projections expect a top-line growth to DKK 108m by FY 2027/28, driven by a 61% CAGR.